Identifes nanobodies that suits any purpose by way of screening their vast synthetic library

Discovery and development of novel antibiotics to treat multidrug-resistant infections. 

Specialized in fusion molecules based on secondary metabolites from eukaryotes.

Developing game-changing alternatives to fossil-based plastics

Develops enzyme-powered topical products for improved management of skin conditions

Arxx Therapeutics develops a first-in-class monoclonal antibody with a unique mechanism of action targeting non-resolving tissue fibrosis

Developing diagnostic self-tests‍

Bringing safe and affordable drinking water to low income communities.